Mind This Psychedelic Medicine Stock
Mental health issues are on the rise – and so is demand for treatments for mental health disorders based on psychedelic substances.
Mental health issues are on the rise – and so is demand for treatments for mental health disorders based on psychedelic substances.
As PDUFA dates can serve as catalysts for stocks, biotech investors can be well served by paying attention to them.
What do these impending decisions mean for healthcare and biotech stocks?
A year or so ago, the gene therapy trend was hot – until it quickly cooled down. But now may be the time to get… Read More »Follow The Smart Money Back Into The Gene Therapy Trend With This Biotech
The biotech featured in today’s article “selects product candidates for diseases and conditions that represent a significant unmet medical need, have well-understood biology, and provide… Read More »What Makes This Biotech A “Strong Buy”? An Underappreciated – And Potentially Transformative – Late-Stage Pipeline
Companies involved in biopharmaceuticals, life sciences, stem cell therapies, COVID test kits and traumatic brain injury treatment using psychedelic and naturally-sourced therapies are among the… Read More »Why This Biotech Startup Could Be A Moderna In The Making
Companies involved in biopharmaceuticals, life sciences, stem cell therapies, COVID test kits and traumatic brain injury treatment using psychedelic and naturally-sourced therapies are among the… Read More »New Stocks To Watch In Biotech, Tech, Mining & Green Energy
“When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.”
“Because biotech penny stocks tend to fluctuate heavily, adding the layer of Reddit makes them even more volatile. So understanding how to trade penny stocks… Read More »Read Up On These 4 Reddit Biotech Penny Stocks
“These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential,” says the author of today’s… Read More »5 Stocks Under $10 With Big Upside Potential – Including 2 Microcap Biotech Stocks